Inhibitors of Catechol-O-Methyltransferase

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 324-332

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 13, Iss. 3, 2013-09 ,pp. : 166-194

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: A PET study with 6-[ 18 F]l-DOPA

By Doudet D.J.   Chan G.L.Y.   Holden J.E.   Pate B.D.   Morrison K.S.   Calne D.B.   Ruth T.J.  

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 31-38

Elsevier

Access to resources Recommend Favorite

Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-DOPA and dopamine in rats

By Napolitano A.   Zurcher G.   Da Prada M.  

European Journal of Pharmacology, Vol. 273, Iss. 3, 1995-02 ,pp. : 215-221

Elsevier

Access to resources Recommend Favorite

Treatment of Cognitive Deficits Associated with Schizophrenia: Potential Role of Catechol-O-Methyltransferase Inhibitors

By Apud José A.   Weinberger Daniel R.  

CNS Drugs, Vol. 21, Iss. 7, 2007-01 ,pp. : 535-557

Adis International

Access to resources Recommend Favorite